Company: BreStem Therapeutics
Job title: Co-Founder
Dr. Cheng is Co-Founder and President of BreStem Therapeutics, a clinical stage company focusing on lung regenerative medicine. In his academic job, Dr. Cheng is also Randall B. Terry, Jr. Distinguished Professor of Regenerative Medicine, at the Molecular Biomedical Science Department of NC State University and at the Biomedical Engineering Department (joint with UNC-Chapel Hill), NC, USA Dr. Cheng’s research lies at the interface of stem cell therapy, biomaterials, and nanomedicine. His lab is using both cellular (adult and tissue-specific stem cells) and acellular approaches (such as secretome, exosome, and microRNAs) to address degenerative diseases in heart and lung diseases, as well as for skin and hair regeneration. The work in the Cheng Lab has been translated into Phase 1 clinical trials and commercialized into several university start-ups.